πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 2,639 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10434063

Implant compositions for the unidirectional delivery of therapeutic compounds to the brain

The Board of Regents of the University of Texas System Β· Granted Tue Oct 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10434075

FKBP52 specific androgen receptor inhibitor, MJC13, for use in treating breast cancer

The Board of Regents of the University of Texas System Β· Granted Tue Oct 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10435435

Quinstatin compounds

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Tue Oct 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10428115

Dynorphin A analogs with bradykinin receptors specificity for modulation of neuropathic pa

Arizona Board of Regents on Behalf of the University of Arizona Β· Granted Tue Oct 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10428159

Blocking monoclonal antibodies to AGR2 and its receptor C4.4A

The Board of Regents of the University of Texas System Β· Granted Tue Oct 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10428057

Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of

The Board of Regents of the University of Texas System Β· Granted Tue Oct 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10420758

Indolinyl-sulfonamide inhibitors of tankyrase and methods of use thereof

The Board of Regents of the University of Texas System Β· Granted Tue Sep 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10420833

Combinatorial platform for the display of surface adjuvants and antigens

The Board of Regents of the University of Texas System Β· Granted Tue Sep 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10421765

Tetrahydropyrido[4,3-d]pyrimidine inhibitors of ATR kinase

The Board of Regents of the University of Texas System Β· Granted Tue Sep 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10420720

Volatile anesthetic compositions comprising extractive solvents for regional anesthesia an

The Board of Regents of the University of Texas System Β· Granted Tue Sep 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10413602

Fungal immunogens and related materials and methods

Arizona Board of Regents on Behalf of the University of Arizona Β· Granted Tue Sep 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10414725

Pyrrolomycins and methods of using the same

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA Β· Granted Tue Sep 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10416174

Diagnosis and prognosis for chronic fatigue syndrome

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Tue Sep 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10407495

Bispecific antibody fragments for neurological disease proteins and methods of use

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Tue Sep 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10406167

Texaphyrin-Pt(IV) conjugates and compositions for use in overcoming platinum resistance

The Board of Regents of the University of Texas System Β· Granted Tue Sep 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10406248

Molecular imaging of cancer cells in vivo

Arizona Board of Regents on Behalf of the University of Arizona Β· Granted Tue Sep 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10398661

Methods for classifying a cancer as susceptible to TMEPAI-directed therapies and treating

The Board of Regents of the University of Texas System Β· Granted Tue Sep 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10398668

Glutamate treatment of cardiovascular disorders

The Board of Regents of the University of Oklahoma Β· Granted Tue Sep 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10398680

Methods of treating muscular dystrophy

BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE OF THE UNIVERSITY OF NEVADA, RENO Β· Granted Tue Sep 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10398682

Methods and compositions to prevent or treat bacterial infections

The Board of Regents of the University of Texas System Β· Granted Tue Sep 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10398749

Methods of treating muscular dystrophy

BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE OF THE UNIVERSITY OF NEVADA, RENO Β· Granted Tue Sep 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10392642

High molecular weight heparosan polymers and methods of production and use thereof

The Board of Regents of the University of Oklahoma Β· Granted Tue Aug 27 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10391183

Infectivity-enhanced conditionally-replicative adenovirus and uses thereof

The Board of Regents of the University of Texas System Β· Granted Tue Aug 27 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10392376

Heterocyclic inhibitors of ATR kinase

The Board of Regents of the University of Texas System Β· Granted Tue Aug 27 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted